The global secondary myelofibrosis therapeutics market is poised for significant growth, with an estimated market value of USD 2.74 billion by 2033, marking a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period of 2023 to 2033. This promising market growth comes on the heels of a market value of USD 1.49 billion …
Author Archives: Pranali Shahapurkar
Global Neovascular Age-Related Macular Degeneration Treatment Market Set for Significant Growth: Projected to Reach USD 4.89 Billion by 2033
According to the latest market research report by Future Market Insights, the global neovascular age-related macular degeneration treatment market is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) of 5% from 2023 to 2033. Valued at USD 3 billion in 2023, the market is anticipated to reach an impressive USD 4.89 …
Global Lupus Nephritis Treatment Market to Reach USD 5.67 Billion by 2033, Driven by Rising Incidence and Advancements in Treatment: FMI Study
The global lupus nephritis treatment market, valued at USD 2 billion in 2023, is set to experience significant growth, reaching an estimated market value of USD 5.67 billion by 2033. This expansion reflects a compound annual growth rate (CAGR) of 11% during the forecast period from 2023 to 2033. Several factors contribute to this upward …
Global Focal Segmental Glomerulosclerosis (FSGS) Therapeutics Market Poised for Significant Growth, Projected to Reach USD 4.89 Billion by 2033
The global focal segmental glomerulosclerosis (FSGS) therapeutics market is on track to achieve remarkable growth, with projections indicating a market value of USD 4.89 billion by 2033, up from USD 3 billion in 2023. This expansion represents a CAGR of 5% from 2023 to 2033, reflecting the growing demand for effective treatment solutions for this …
Global Hepatic Encephalopathy Treatment Market on a Robust Growth Trajectory: Expected to Reach USD 2971.51 Million by 2033 registering a CAGR of 6.5%
The global hepatic encephalopathy treatment market is set to achieve significant growth, with projections indicating an increase from USD 1583 Million in 2023 to USD 2971.51 Million by 2033, reflecting a CAGR of 6.5% during the forecast period. The market witnessed a moderate growth rate of 3.9% CAGR during the historical period of 2018 to …
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market to reach USD 6.82 billion by 2033, expanding at a CAGR of 6.9%: FMI Report
The global chimeric antigen receptor (CAR) T-Cell therapy market is witnessing remarkable growth, with its market value surging from USD 2.54 billion in 2022 to an anticipated USD 3.5 billion in 2023, and further projected to reach a staggering USD 6.82 billion by 2033, according to recent industry reports. This represents a compound annual growth …
Global Crohn’s Disease Treatment Market Set to Reach USD 17.80 Billion by 2033 at a steady 4.3% CAGR, Driven by Rising Incidence and Demand for Advanced Therapies | FMI
The global market for Crohn’s disease (CD) treatment is on a significant growth trajectory, projected to reach approximately USD 17.80 billion by the end of 2033. This substantial increase, up from USD 11.68 billion in 2023, reflects a compound annual growth rate (CAGR) of 4.3%, according to a comprehensive report by Future Market Insights. The …
Global AL Amyloidosis Therapeutics Market Set for Remarkable Growth, Projected to Reach USD 4.56 Billion by 2033 rise at a 7.3% CAGR
Future Market Insights, a leading market research firm, has unveiled a comprehensive report forecasting significant expansion in the global AL amyloidosis therapeutics market. According to the report, the market is poised to grow from USD 2.25 billion in 2023 to a remarkable USD 4.56 billion by 2033, registering a robust Compound Annual Growth Rate (CAGR) …
Global Post-Traumatic Stress Disorder Treatment Market to reach USD 27.37 billion by 2033; Antidepressants to be Most Consumed: FMI Report
The global post-traumatic stress disorder treatment market is set for significant growth, with its valuation expected to climb from USD 16.8 billion in 2023 to an impressive USD 27.37 billion by 2033, reflecting a robust CAGR of 5% during the forecast period from 2023 to 2033. This surge is attributed to the continuous innovation in …
Nutritional Yeast Market The Plant-Based Powerhouse of the Future
According to the recent FMI report, the sales for nutritional yeast has estimated that the industry is set to reach a net worth of US$ 257.38 million in FY 2024. Reflecting on current consumer trends, key players are offering multifunctional food and beverages that contain healthy ingredients like nutritional yeast, also known as deactivated yeast. The nutritional …
Continue reading “Nutritional Yeast Market The Plant-Based Powerhouse of the Future”